Value Sense
RMD
ResMed Inc. (RMD)
Last Price$233.1(0.2%)
Market Cap$34.6B
LTM Revenue
$4,926.8M
+12.9% YoY
LTM Net Income
$1,248.7M
+40.2% YoY
LTM Net Debt
$317.8M
Net Debt to FCF - 0.2x
LTM Free Cash Flow (FCF)
$1,388.4M
28.2% margin

RMD Income Statement

RMD Income Statement Overview

Annual
Quarterly
LTM
Jun'15
Jun'16
Jun'17
Jun'18
Jun'19
Jun'20
Jun'21
Jun'22
Jun'23
Jun'24
Revenue
$4,685.3M 10.9% YoY
Gross profit
$2,655.3M 12.7% YoY
56.7% margin
Cost of revenue
$2,030.0M 8.7% YoY
Operating income
$1,319.9M 16.6% YoY
28.2% margin
Other: $9,387.0K
Net interest: $45.7M
Operating expenses
$1,335.4M 10.9% YoY
Pre-tax income
$1,264.8M 14.8% YoY
27.0% margin
Net income
$1,021.0M 13.7% YoY
21.8% margin
Income tax
$243.8M
19.3% tax rate
R&D
$307.5M 6.9% YoY
6.6% of revenue
SG&A
$917.1M 4.9% YoY
19.6% of revenue

RMD Income statement key metrics

Annual
Quarterly
LTM

Revenue

$4,685.3M +10.9% YoY

Operating Income

$1,319.9M +16.6% YoY

Net Income

$1,021.0M +13.7% YoY

RMD Balance Sheet

RMD Balance Sheet Overview

Annual
Quarterly
LTM
Jun'15
Jun'16
Jun'17
Jun'18
Jun'19
Jun'20
Jun'21
Jun'22
Jun'23
Jun'24
Assets
Liabilities
Total assets
$6,872.4M
Current assets ($2,357.7M, 34.3% of total)
Cash & ST investments
$238.4M (3.5%)
Accounts receivables
$837.3M (12.2%)
Other current assets
$1,282.1M (18.7%)
Non-current assets ($4,514.7M, 65.7% of total)
Long-term investments
$169.8M (2.5%)
Intangible assets
$485.9M (7.1%)
Other non-current assets
$3,159.9M (46.0%)
Financial position
Net Debt
$660.9M
$238.4M$899.2M
Cash & Short-term Investments
Total Debt
Quick ratio
1.2x
Net Debt to Free Cash Flow
0.5x
Debt to Equity ratio
18.5%

RMD Balance Sheet Metrics

Annual
Quarterly
LTM

Assets

$6,872.4M +1.8% YoY

Liabilities

$2,008.4M -23.4% YoY

Shareholder's Equity

$4,864.0M +17.8% YoY

RMD Cash Flow Statement

RMD Cash Flow Statement Overview

Annual
Quarterly
LTM
Jun'15
Jun'16
Jun'17
Jun'18
Jun'19
Jun'20
Jun'21
Jun'22
Jun'23
Jun'24
Cash Beginning of PeriodOperating Cash FlowInvesting Cash FlowFinancing Cash FlowForex Changes on CashCash End of Period$227.9M$1,401.3M($269.8M)($1,119.3M)($1,719.0K)$238.4M

RMD Cash Flow Statement key metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$1,401.3M +102.1% YoY

Capital Expenditure (CAPEX)

($114.9M) -14.3% YoY

Free Cash Flow (FCF)

$1,286.4M +130.0% YoY

RMD Financials

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Jun'05Jun'06Jun'07Jun'08Jun'09Jun'10Jun'11Jun'12Jun'13Jun'14Jun'15Jun'16Jun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24
Revenue
% growth
425.5
25.4%
607.0
42.7%
716.3
18.0%
835.4
16.6%
920.7
10.2%
1,092.4
18.6%
1,243.1
13.8%
1,368.5
10.1%
1,514.5
10.7%
1,555.0
2.7%
1,678.9
8.0%
1,838.7
9.5%
2,066.7
12.4%
2,340.2
13.2%
2,606.6
11.4%
2,957.0
13.4%
3,196.8
8.1%
3,578.1
11.9%
4,223.0
18.0%
4,685.3
10.9%
Cost of Goods Sold (COGS)150.6230.1331.8341.6366.9436.9501.8547.8573.8565.2667.5772.2865.0978.01,070.01,239.21,357.71,553.81,867.32,030.0
Gross Profit
% margin
274.9
64.6%
376.9
62.1%
384.5
53.7%
493.8
59.1%
553.8
60.1%
655.5
60.0%
741.3
59.6%
820.7
60.0%
940.7
62.1%
989.8
63.7%
1,011.4
60.2%
1,066.5
58.0%
1,201.7
58.1%
1,362.2
58.2%
1,536.6
59.0%
1,717.8
58.1%
1,839.1
57.5%
2,024.3
56.6%
2,355.7
55.8%
2,655.3
56.7%
Operating Expenses167.1244.5294.3348.4360.0412.1473.4525.3585.8578.4596.2625.2745.0801.9900.6908.7926.71,024.01,203.71,335.4
Research & Development Expenses (R&D)30.037.250.160.563.175.292.0109.7120.1118.2114.9118.7144.5155.1180.7201.9225.3253.6287.6307.5
Selling, General & Administrative Expenses (SG&A)135.7200.2237.3278.1289.9328.9371.2401.6430.8450.4472.6482.6554.0600.4645.0676.7670.4739.4874.0917.1
Operating Income
% margin
97.4
22.9%
131.3
21.6%
90.2
12.6%
143.0
17.1%
190.3
20.7%
240.4
22.0%
266.9
21.5%
294.4
21.5%
354.8
23.4%
405.1
26.1%
409.2
24.4%
429.0
23.3%
425.8
20.6%
541.8
23.2%
579.3
22.2%
809.7
27.4%
903.7
28.3%
1,000.3
28.0%
1,131.9
26.8%
1,319.9
28.2%
Interest Income0.00.00.00.00.016.727.833.938.931.226.216.917.116.42.31.00.422.347.40.0
Interest Expense0.01.31.310.110.110.11.84.86.46.15.811.228.228.436.240.424.022.347.445.7
Pre-tax Income96.6133.498.0157.9201.7260.6303.7331.9385.1431.1435.9439.6418.7521.3518.8733.1883.7960.51,101.71,264.8
Income Tax
% effective tax rate
31.8
33.0%
45.2
33.9%
31.7
32.3%
47.6
30.1%
55.2
27.4%
70.5
27.1%
76.7
25.3%
77.1
23.2%
78.0
20.2%
85.8
19.9%
83.0
19.0%
87.2
19.8%
76.5
18.3%
205.7
39.5%
114.3
22.0%
111.4
15.2%
409.2
46.3%
181.0
18.8%
204.1
18.5%
243.8
19.3%
Net Income
% margin
64.8
15.2%
88.2
14.5%
66.3
9.3%
110.3
13.2%
146.4
15.9%
190.1
17.4%
227.0
18.3%
254.9
18.6%
307.1
20.3%
345.3
22.2%
352.9
21.0%
352.4
19.2%
342.3
16.6%
315.6
13.5%
404.6
15.5%
621.7
21.0%
474.5
14.8%
779.4
21.8%
897.6
21.3%
1,021.0
21.8%
EPS0.470.610.430.720.971.261.491.752.152.442.512.512.422.212.834.313.275.346.126.94
Diluted EPS0.460.580.430.700.951.231.441.712.102.392.472.492.402.192.804.273.245.306.096.92
EBITDA
% margin
136.9
32.2%
174.0
28.7%
90.2
12.6%
204.8
24.5%
190.3
20.7%
322.2
29.5%
374.3
30.1%
422.6
30.9%
469.8
31.0%
484.9
31.2%
482.3
28.7%
522.7
28.4%
568.9
27.5%
680.2
29.1%
705.8
27.1%
990.4
33.5%
1,099.2
34.4%
1,176.6
32.9%
1,358.8
32.2%
1,533.5
32.7%

FAQ

What is the ResMed Inc. (RMD) revenue?

The ResMed Inc. (RMD) revenue is $4,685.3M, reflecting a year-over-year (YoY) growth of +10.9% YoY.

What is the ResMed Inc. (RMD) Net Income?

The ResMed Inc. (RMD) Net Income is $1,021.0M, showcasing a YoY growth of +13.7% YoY.